Should we reconsider cefazolin for treating staphylococcal meningitis? A retrospective analysis of cefazolin and cloxacillin cerebrospinal fluid levels in patients treated for staphylococcal meningitis
Paul Le Turnier, Matthieu Grégoire, Guillaume Deslandes, Karim Lakhal, Colin Deschanvres, R. Lecomte, J.-P. Talarmin, Vincent Dubée, Ronan Bellouard, David Boutoille, Anne‐Gaëlle Leroy, Benjamin Gaborit, François Raffi, David Boutoille, Charlotte Biron, M. Lefèbvre, Benjamin Gaborit, Paul Le Turnier, Colin Deschanvres, R. Lecomte, Marie Chauveau, Nathalie Asseray, Matthieu Grégoire, Ronan Bellouard, Guillaume Deslandes, Éric Dailly, Anne‐Gaëlle Leroy, Stéphane Corvec, Pascale Bémer, J. Caillon, A. Guillouzouic, Karim Lakhal, Raphaël Cinotti, Emmanuel Canet, Cédric Bretonnière, Thomas Guimard, Julia Brochard, J.-P. Talarmin, Lydie Katchatourian
Topics & Concepts
CloxacillinCefazolinMedicineMeningitisInterquartile rangeStaphylococcal infectionsMicrobiologyAnesthesiaAntibioticsSurgeryStaphylococcus aureusPenicillinBiologyBacteriaGeneticsBacterial Infections and VaccinesAntibiotics Pharmacokinetics and EfficacyAntimicrobial Resistance in Staphylococcus